Lista de obras - Benjamin Mullish - Dominio Público Uruguay

1171. Impact on Mortality, Length of Stay, and Antibiotic Use in Allogenic and Autologous Stem Cell Transplant Patients Colonized With Carbapenemase-Producing Enterobacteriaceae

A Guide to the Gut Microbiome and its Relevance to Critical Care

artículo científico publicado en 2020

A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being

artículo científico publicado en 2020

Antibiotic therapy and outcome from immune-checkpoint inhibitors

scientific article published on 06 November 2019

Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant

artículo científico publicado en 2018

Anticoagulation in chronic liver disease

artículo científico publicado en 2017

Changes in IgA-targeted microbiota following fecal transplantation for recurrent <i>Clostridioides difficile</i> infection

artículo científico publicado en 2021

Clostridium difficile infection and antibiotic-associated diarrhoea

scientific article published on 01 June 2018

Comparative epidemiology of Clostridium difficile infection: England and the USA.

artículo científico publicado en 2017

Current and future pharmacological therapies for managing cirrhosis and its complications

artículo científico publicado en 2019

Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume

scientific article published on 05 March 2019

Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease - authors' reply

artículo científico publicado en 2019

Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway

scholarly article by Tanya Monaghan et al published 5 September 2018 in Gut microbes

Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients

scientific article published on 10 July 2019

Faecal microbiota transplant for eradication of multidrug-resistant Enterobacteriaceae: a lesson in applying best practice? Re: 'A five-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant En

scientific article published on 25 January 2019

Faecal microbiota transplant: a novel biological approach to extensively drug-resistant organism-related non-relapse mortality.

artículo científico publicado en 2017

Faecal microbiota transplantations and urinary tract infections - Authors' reply

scientific article published on 01 January 2020

Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial

artículo científico publicado en 2019

Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial

artículo científico publicado en 2017

Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders

scientific article published on 01 August 2020

Functional microbiomics: Evaluation of gut microbiota-bile acid metabolism interactions in health and disease

article

Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy

artículo científico publicado en 2023

Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease

artículo científico publicado en 2019

Gastrointestinal: Duodenal variceal bleeding secondary to thrombophilia-related portal vein thrombosis

artículo científico publicado en 2018

High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease

scientific article published on 27 December 2019

Identifying the factors influencing outcome in probiotic studies in overweight and obese patients: host or microbiome?

artículo científico publicado en 2020

Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms

artículo científico publicado en 2019

In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation

artículo científico publicado en 2019

Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota

artículo científico publicado en 2018

International consensus conference on stool banking for faecal microbiota transplantation in clinical practice

artículo científico publicado en 2019

Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, 'COVID-19: Immunology and treatment options', Felsenstein, Herbert McNamara et al. 2020'

artículo científico publicado en 2020

Introduction to the joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) faecal microbiota transplant guidelines

artículo científico publicado en 2018

Letter: depression and the use of anti-depressants in patients with chronic liver disease or liver transplantation - authors' reply.

artículo científico publicado en 2015

Letter: faecal microbiota transplantation for IBS

scientific article published on 01 August 2020

Letter: improvements in mental health after faecal microbiota transplantation-an underexplored treatment-related benefit?

artículo científico publicado en 2018

Letter: intestinal microbiota transfer-updating the nomenclature to increase acceptability

scientific article published on 01 November 2020

Letter: liver disease and COVID-19-not the perfect storm

scientific article published on 01 August 2020

Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease-authors' reply

scientific article published on 01 November 2019

Long term outcomes of initial infliximab therapy for inflammatory pouch pathology: a multi-Centre retrospective study

scientific article published on 29 September 2018

Mechanisms underpinning the efficacy of faecal microbiota transplantation in treating gastrointestinal disease

scientific article published on 03 September 2020

Meeting update: faecal microbiota transplantation--bench, bedside, courtroom?

artículo científico publicado en 2016

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection

scientific article published on 11 February 2019

Microbiome manipulation with faecal microbiome transplantation as a therapeutic strategy in Clostridium difficile infection

artículo científico publicado en 2014

NAFLD: Time to apply quantitation in liver biopsies as endpoints in clinical trials

scientific article published on 02 October 2020

National survey of practice of faecal microbiota transplantation for Clostridium difficile infection in the UK.

artículo científico publicado en 2016

Non-Alcoholic Fatty Liver Disease and Vascular Disease

scientific article published on 17 March 2020

Non-alcoholic fatty liver disease and cardiovascular risk: an update

artículo científico publicado en 2018

Obstacles to establishing an NHS faecal transplant programme

artículo científico publicado en 2015

Optimized Sample Handling Strategy for Metabolic Profiling of Human Feces.

artículo científico publicado en 2016

Recurrent bacteraemia following variceal haemorrhage

artículo científico publicado en 2019

Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic

artículo científico publicado en 2020

Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation

artículo científico publicado en 2014

Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel

scientific article published on 17 March 2020

Severe cholestatic jaundice after a single administration of ajmaline; a case report and review of the literature

artículo científico publicado en 2014

Shoulder pain and dysphagia with an unexpected cause

artículo científico publicado en 2011

The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease

artículo científico publicado en 2019

The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications

artículo científico publicado en 2019

The implementation of omics technologies in cancer microbiome research

artículo científico publicado en 2018

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

artículo científico publicado en 2018

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

scientific article published on 01 September 2018

Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites

artículo científico publicado en 2020

Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy

scientific article published on 03 March 2020

Weight loss in a man from West Africa. S. stercoralis hyperinfection

artículo científico publicado en 2015

Lista de obras de Benjamin Mullish

1171. Impact on Mortality, Length of Stay, and Antibiotic Use in Allogenic and Autologous Stem Cell Transplant Patients Colonized With Carbapenemase-Producing Enterobacteriaceae

A Guide to the Gut Microbiome and its Relevance to Critical Care

A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being

Antibiotic therapy and outcome from immune-checkpoint inhibitors

Antibiotic-Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant

Anticoagulation in chronic liver disease

Changes in IgA-targeted microbiota following fecal transplantation for recurrent <i>Clostridioides difficile</i> infection

Clostridium difficile infection and antibiotic-associated diarrhoea

Comparative epidemiology of Clostridium difficile infection: England and the USA.

Current and future pharmacological therapies for managing cirrhosis and its complications

Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume

Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease - authors' reply

Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway

Effects of Fecal Microbiota Transplantation With Oral Capsules in Obese Patients

Faecal microbiota transplant for eradication of multidrug-resistant Enterobacteriaceae: a lesson in applying best practice? Re: 'A five-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant En

Faecal microbiota transplant: a novel biological approach to extensively drug-resistant organism-related non-relapse mortality.

Faecal microbiota transplantations and urinary tract infections - Authors' reply

Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial

Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial

Fecal microbiota transplantation in gastrointestinal and extraintestinal disorders

Functional microbiomics: Evaluation of gut microbiota-bile acid metabolism interactions in health and disease

Future Modulation of Gut Microbiota: From Eubiotics to FMT, Engineered Bacteria, and Phage Therapy

Gaps in knowledge and future directions for the use of faecal microbiota transplant in the treatment of inflammatory bowel disease

Gastrointestinal: Duodenal variceal bleeding secondary to thrombophilia-related portal vein thrombosis

High-Throughput, Machine Learning-Based Quantification of Steatosis, Inflammation, Ballooning, and Fibrosis in Biopsies From Patients With Nonalcoholic Fatty Liver Disease

Identifying the factors influencing outcome in probiotic studies in overweight and obese patients: host or microbiome?

Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms

In search of stool donors: a multicenter study of prior knowledge, perceptions, motivators, and deterrents among potential donors for fecal microbiota transplantation

Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota

International consensus conference on stool banking for faecal microbiota transplantation in clinical practice

Intestinal microbiome transfer, a novel therapeutic strategy for COVID-19 induced hyperinflammation?: In reply to, 'COVID-19: Immunology and treatment options', Felsenstein, Herbert McNamara et al. 2020'

Introduction to the joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) faecal microbiota transplant guidelines

Letter: depression and the use of anti-depressants in patients with chronic liver disease or liver transplantation - authors' reply.

Letter: faecal microbiota transplantation for IBS

Letter: improvements in mental health after faecal microbiota transplantation-an underexplored treatment-related benefit?

Letter: intestinal microbiota transfer-updating the nomenclature to increase acceptability

Letter: liver disease and COVID-19-not the perfect storm

Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease-authors' reply

Long term outcomes of initial infliximab therapy for inflammatory pouch pathology: a multi-Centre retrospective study

Mechanisms underpinning the efficacy of faecal microbiota transplantation in treating gastrointestinal disease

Meeting update: faecal microbiota transplantation--bench, bedside, courtroom?

Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection

Microbiome manipulation with faecal microbiome transplantation as a therapeutic strategy in Clostridium difficile infection

NAFLD: Time to apply quantitation in liver biopsies as endpoints in clinical trials

National survey of practice of faecal microbiota transplantation for Clostridium difficile infection in the UK.

Non-Alcoholic Fatty Liver Disease and Vascular Disease

Non-alcoholic fatty liver disease and cardiovascular risk: an update

Obstacles to establishing an NHS faecal transplant programme

Optimized Sample Handling Strategy for Metabolic Profiling of Human Feces.

Recurrent bacteraemia following variceal haemorrhage

Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic

Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation

Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel

Severe cholestatic jaundice after a single administration of ajmaline; a case report and review of the literature

Shoulder pain and dysphagia with an unexpected cause

The application of omics techniques to understand the role of the gut microbiota in inflammatory bowel disease

The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications

The implementation of omics technologies in cancer microbiome research

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines

Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites

Ursodeoxycholic acid enriches intestinal bile salt hydrolase-expressing Bacteroidetes in cholestatic pregnancy

Weight loss in a man from West Africa. S. stercoralis hyperinfection